CUDOS: Clinically Useful Depression Outcome Scale

What this assessment is

The CUDOS, or Clinically Useful Depression Outcome Scale, is an 18-item self-report measure of depressive symptoms and their effect on daily life.

Mark Zimmerman and colleagues developed it for routine clinical measurement. The original validation study describes a form designed to take less than three minutes and remain sensitive to change.

The CUDOS measures symptom severity. It does not diagnose depression.

Who it was designed for

The original study tested psychiatric outpatients, including adults with and without depressive disorders, and designed the scale for repeated use during care.

It may help a clinician and patient see whether reported symptoms are changing. The same version, timeframe, language, and scoring method should be used at each measurement.

Evidence from psychiatric outpatient care does not automatically establish performance in every community, age group, or medical setting.

How it is administered

The CUDOS asks about the past week, including the day of completion, and gives each item five response levels from 0 to 4.

The measure is completed by the respondent. It was designed for quick scoring in routine practice.

The VA measurement toolkit describes an 18-item form that usually takes less than three minutes.

What it measures

The CUDOS covers symptoms across the depression spectrum and records their effect on daily life and overall quality of life.

This gives the scale a wider range than some shorter depression screens. One total still cannot show which symptom or life area drove the result.

The CUDOS was built around DSM-IV symptom descriptions. A current diagnosis requires a current clinical assessment, not a score conversion.

How scoring works

Each of the 18 responses contributes 0 to 4 points, and the values are added for a total from 0 to 72.

Higher totals indicate more severe reported depression-related symptoms and impact during the past week.

The published scoring method is a straight sum. The sources reviewed for this page do not give a universal rule for missing responses.

Do not replace a missing answer with zero. A local service should use a stated, source-supported completeness rule.

How to interpret a CUDOS score

The developers proposed these approximate ranges:

• 0 to 10: nondepressed range
• 11 to 20: minimal range
• 21 to 30: mild range
• 31 to 45: moderate range
• 46 to 72: severe range

These ranges came from the developers' data and clinical experience, but they were presented as approximations rather than diagnostic boundaries.

The label nondepressed does not rule out a depressive disorder. A score can also be affected by treatment, recent events, physical health, and the person's interpretation of the response choices.

The most useful comparison is often change within the same person under the same method. A smaller total suggests fewer reported symptoms, but it does not prove recovery.

A score does not replace a safety check

The CUDOS includes questions about wishing for death and thinking about suicide. Any endorsement needs direct review, regardless of the total.

Safety comes first.

Ask about current thoughts, intent, plan, means, protective factors, and available support. A low total does not make a concerning response unimportant.

What the score cannot tell you

The CUDOS cannot confirm or rule out a depressive disorder or explain whether symptoms come from depression, grief, illness, medication, substance use, sleep disruption, or another condition.

It cannot choose treatment or determine urgency by itself. Clinical decisions require direct assessment of symptoms, function, history, safety, and context.

Evidence and limitations

The original study tested more than 1,400 psychiatric outpatients and found high reliability, expected correlations with other depression measures, and sensitivity to symptom change.

A later Korean validation study also found strong measurement properties in psychiatric outpatients. That study used a translated version and proposed a screening cutoff for its own sample.

The evidence supports measurement, not automatic diagnosis. Population, language, setting, and purpose still control interpretation.